Scleromyxedema: Successful treatment with thalidomide in two patients

Dermatology

Volumn 214, Issue 1, 2006, Pages 58-60

  Amini Adle, Mona ^a   Thieulent, Nadege ^a   Dalle, Stéphane ^a   Balme, Brigitte ^a   Thomas, Luc ^a  

^a HÔTEL DIEU   (France)

Author keywords

Scleromyxedema; Thalidomide; TNF

Indexed keywords

CHLORAMBUCIL; IMMUNOGLOBULIN LAMBDA CHAIN; MELPHALAN; THALIDOMIDE; TUMOR NECROSIS FACTOR;

ADULT; AGED; ARTICLE; BLOOD CELL COUNT; BONE MARROW BIOPSY; CASE REPORT; CELL PROLIFERATION; DAILY LIFE ACTIVITY; DERMIS; DISABILITY; DIZZINESS; DRUG DOSE REDUCTION; DRUG EFFICACY; FEMALE; FIBROBLAST; HISTOLOGY; HUMAN; NONHODGKIN LYMPHOMA; PAPULE; PHOTOCHEMOTHERAPY; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; SCLEROMYXEDEMA; T LYMPHOCYTE; THYROID FUNCTION;

ADULT; AGED; CELL PROLIFERATION; FEMALE; FIBROBLASTS; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; RETROSPECTIVE STUDIES; SCLEROMYXEDEMA; THALIDOMIDE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33845936018     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096914     Document Type: Article

References (6)

1. Caradonna S, Jacobe H: Thalidomide as a potential treatment for scleromyxedema. Arch Dermatol 2004;140:277-280.
2. Sansbury JC, Cocuroccia B, Jorizzo JL, Gubinelli E, Gisondi P, Girolomoni G: Treatment of recalcitrant scleromyxedema with thalidomide in 3 patients. J Am Acad Dermatol 2004;51:126-131. Erratum in: J Am Acad Dermatol 2004;51:722.
3. Jacobson JM, Greenspan JS, Spritzler J, Ketter N, Fahey JL, Jackson JB, Fox L, Chernoff M, Wu AW, MacPhail LA, Vasquez GJ, Wohl DA: Thalidomide for the treatment of oral aphthous ulcers in patients with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 1997;336:1487-1493.
4. Wolkenstein P, Latarjet J, Roujeau JC, Duguet C, Boudeau S, Vaillant L, Maignan M, Schuhmacher MH, Milpied B, Pilorget A, Bocquet H, Brun-Buisson C, Revuz J: Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis. Lancet 1998;352:1586-1589.
5. Haslett PA, Corral LG, Albert M, Kaplan G: Thalidomide costimulates primary human T lymphocytes, preferentially inducing proliferation, cytokine production, and cytotoxic responses in the CD8+ subset. J Exp Med 1998;187:1885-1892.
6. Sander CS, Kaatz M, Elsner P: Successful treatment of cutaneous Langerhans cell histiocytosis with thalidomide. Dermatology 2004;208:149-152.